Visionary Physicist's Crusade Serves As Lesson In Futility

PRINCETON, NJ.—Drop a certain name in conversation with a fusion scientist or a Department of Energy official and you’re likely to observe an unusual reaction. Rolling eyes and sighs are common responses; mild cases of apoplexy are not unknown. Usually composed researchers become animated, others simply nod their heads knowingly. Rarely does the name pass without comment. The name is Bogdan Maglich, and the man who owns it claims he’s just a scientist with a relatively mo

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

PRINCETON, NJ.—Drop a certain name in conversation with a fusion scientist or a Department of Energy official and you’re likely to observe an unusual reaction. Rolling eyes and sighs are common responses; mild cases of apoplexy are not unknown. Usually composed researchers become animated, others simply nod their heads knowingly. Rarely does the name pass without comment.

The name is Bogdan Maglich, and the man who owns it claims he’s just a scientist with a relatively modest request: He’d like $2 million with which to build a fusion device smaller than a cubic centimeter, with an output of one kilowatt and practically no radioactivity. He calls it a “migma,” and he says that hundreds of migmas can be strung together to form enormous power plants.

Maglich is sure it will work. So sure, in fact, that he has formed a company, Advanced Physics Corp., to promote the idea. Its board ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Robert Crease

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo